BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 22059533)

  • 1. Induction of methionine-sulfoxide reductases protects neurons from amyloid β-protein insults in vitro and in vivo.
    Moskovitz J; Maiti P; Lopes DH; Oien DB; Attar A; Liu T; Mittal S; Hayes J; Bitan G
    Biochemistry; 2011 Dec; 50(49):10687-97. PubMed ID: 22059533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methionine sulfoxide reductase A affects β-amyloid solubility and mitochondrial function in a mouse model of Alzheimer's disease.
    Moskovitz J; Du F; Bowman CF; Yan SS
    Am J Physiol Endocrinol Metab; 2016 Mar; 310(6):E388-93. PubMed ID: 26786779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surprising toxicity and assembly behaviour of amyloid β-protein oxidized to sulfone.
    Maiti P; Piacentini R; Ripoli C; Grassi C; Bitan G
    Biochem J; 2011 Jan; 433(2):323-32. PubMed ID: 21044048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The protein oxidation repair enzyme methionine sulfoxide reductase a modulates Aβ aggregation and toxicity in vivo.
    Minniti AN; Arrazola MS; Bravo-Zehnder M; Ramos F; Inestrosa NC; Aldunate R
    Antioxid Redox Signal; 2015 Jan; 22(1):48-62. PubMed ID: 24988428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidation of methionine 35 reduces toxicity of the amyloid beta-peptide(1-42) in neuroblastoma cells (IMR-32) via enzyme methionine sulfoxide reductase A expression and function.
    Misiti F; Clementi ME; Giardina B
    Neurochem Int; 2010 Mar; 56(4):597-602. PubMed ID: 20060866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Oxidative Stress, Methionine Oxidation and Methionine Sulfoxide Reductases (MSR) in Alzheimer's Disease.
    Chandran S; Binninger D
    Antioxidants (Basel); 2023 Dec; 13(1):. PubMed ID: 38275641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain. A review.
    Butterfield DA
    Free Radic Res; 2002 Dec; 36(12):1307-13. PubMed ID: 12607822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary DHA supplementation in an APP/PS1 transgenic rat model of AD reduces behavioral and Aβ pathology and modulates Aβ oligomerization.
    Teng E; Taylor K; Bilousova T; Weiland D; Pham T; Zuo X; Yang F; Chen PP; Glabe CG; Takacs A; Hoffman DR; Frautschy SA; Cole GM
    Neurobiol Dis; 2015 Oct; 82():552-560. PubMed ID: 26369878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated levels of brain-pathologies associated with neurodegenerative diseases in the methionine sulfoxide reductase A knockout mouse.
    Pal R; Oien DB; Ersen FY; Moskovitz J
    Exp Brain Res; 2007 Jul; 180(4):765-74. PubMed ID: 17333008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of methionine sulfoxide reductase activity by pergolide, pergolide sulfoxide, and S-adenosyl-methionine in neuronal cells.
    Franklin JM; Carrasco GA; Moskovitz J
    Neurosci Lett; 2013 Jan; 533():86-9. PubMed ID: 23178192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a tacrine-8-hydroxyquinoline hybrid (IQM-622) on Aβ accumulation and cell death: involvement in hippocampal neuronal loss in Alzheimer's disease.
    Antequera D; Bolos M; Spuch C; Pascual C; Ferrer I; Fernandez-Bachiller MI; Rodríguez-Franco MI; Carro E
    Neurobiol Dis; 2012 Jun; 46(3):682-91. PubMed ID: 22426395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An effector-reduced anti-β-amyloid (Aβ) antibody with unique aβ binding properties promotes neuroprotection and glial engulfment of Aβ.
    Adolfsson O; Pihlgren M; Toni N; Varisco Y; Buccarello AL; Antoniello K; Lohmann S; Piorkowska K; Gafner V; Atwal JK; Maloney J; Chen M; Gogineni A; Weimer RM; Mortensen DL; Friesenhahn M; Ho C; Paul R; Pfeifer A; Muhs A; Watts RJ
    J Neurosci; 2012 Jul; 32(28):9677-89. PubMed ID: 22787053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decoding the synaptic dysfunction of bioactive human AD brain soluble Aβ to inspire novel therapeutic avenues for Alzheimer's disease.
    Li S; Jin M; Liu L; Dang Y; Ostaszewski BL; Selkoe DJ
    Acta Neuropathol Commun; 2018 Nov; 6(1):121. PubMed ID: 30409172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acetyl-L-carnitine-induced up-regulation of heat shock proteins protects cortical neurons against amyloid-beta peptide 1-42-mediated oxidative stress and neurotoxicity: implications for Alzheimer's disease.
    Abdul HM; Calabrese V; Calvani M; Butterfield DA
    J Neurosci Res; 2006 Aug; 84(2):398-408. PubMed ID: 16634066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cystatin C protects neuronal cells from amyloid-beta-induced toxicity.
    Tizon B; Ribe EM; Mi W; Troy CM; Levy E
    J Alzheimers Dis; 2010; 19(3):885-94. PubMed ID: 20157244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alzheimer's disease amyloid β-protein mutations and deletions that define neuronal binding/internalization as early stage nonfibrillar/fibrillar aggregates and late stage fibrils.
    Poduslo JF; Howell KG; Olson NC; Ramirez-Alvarado M; Kandimalla KK
    Biochemistry; 2012 May; 51(19):3993-4003. PubMed ID: 22545812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New Alzheimer's disease model mouse specialized for analyzing the function and toxicity of intraneuronal Amyloid β oligomers.
    Ochiishi T; Kaku M; Kiyosue K; Doi M; Urabe T; Hattori N; Shimura H; Ebihara T
    Sci Rep; 2019 Nov; 9(1):17368. PubMed ID: 31757975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques.
    Shin MK; Kim HG; Baek SH; Jung WR; Park DI; Park JS; Jo DG; Kim KL
    Neurobiol Aging; 2014 May; 35(5):990-1001. PubMed ID: 24268884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyloid beta and the longest-lived rodent: the naked mole-rat as a model for natural protection from Alzheimer's disease.
    Edrey YH; Medina DX; Gaczynska M; Osmulski PA; Oddo S; Caccamo A; Buffenstein R
    Neurobiol Aging; 2013 Oct; 34(10):2352-60. PubMed ID: 23618870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human intravenous immunoglobulin provides protection against Aβ toxicity by multiple mechanisms in a mouse model of Alzheimer's disease.
    Magga J; Puli L; Pihlaja R; Kanninen K; Neulamaa S; Malm T; Härtig W; Grosche J; Goldsteins G; Tanila H; Koistinaho J; Koistinaho M
    J Neuroinflammation; 2010 Dec; 7():90. PubMed ID: 21138577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.